Terms ending in 2035
Every in-force patent on Torqur AG's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,100,031 | Novel Manufacturing Process for Triazine, Pyrimidine and Pyridine Derivatives In force · High confidence | Torqur AG | In force | High confidence | |
| US 10,766,874 | Novel Manufacturing Process for Triazine, Pyrimidine and Pyridine Derivatives In force · High confidence | Torqur AG | In force | High confidence | |
| US 10,640,516 | Difluoromethyl-Aminopyridines and Difluoromethyl-Aminopyrimidines In force (reinstated) · High confidence | Torqur AG | In force (reinstated) | High confidence | |
| US 11,186,591 | Difluoromethyl-Aminopyridines and Difluoromethyl-Aminopyrimidines In force · High confidence | Torqur AG | In force | High confidence | |
| US 11,878,972 | Treatment of Neurological Disorders In force · Low confidence | Piqur Therapeutics AG | In force | Low confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Torqur AG.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.